Prebiotics: what actually feeds the microbiome
A prebiotic is not a bacterium, it is food. Not every dietary fibre meets the definition. And in a sensitive gut, the selection and the order may matter more than the amount.
All articles in the gut cluster
Few shelves promise as much as the one with the gut powders. And few tools backfire as reliably when they arrive at the wrong moment. Prebiotics are not a starting point. They are a tool for a particular moment.
You are standing in the kitchen reading the back of a tub. Inulin from chicory root, it says. Below that a sentence about a healthy microbiome, next to it a leaf in green.
You thought this through. You do not want to suppress anything, you want to build something up. So you stir a spoonful into water.
Four days later you are sitting on the sofa in the evening, undoing the top button of your trousers, thinking: this cannot be the right direction.
Many people know this pattern. The belly is fuller, not lighter. The flatulence starts earlier in the day. And the obvious conclusion is then: I simply do not tolerate fibre.
That conclusion is understandable, but it stops too early. The evidence says something more precise, and that is the core message of this article: it can make a measurable difference which substrate you take, not only how much.
So this is not about prebiotics for everyone. It is about the right substrate, at the right time, for a particular gut.
What you can expect here
- Four terms cleanly separated: pro, pre, syn and post
- Why not every dietary fibre is a prebiotic
- Each substrate on its own, with a number and with a limit
- What really forms when rice and potatoes cool down
- Butyrate, propionate, acetate and why faecal butyrate misleads
- Why building up before calming down often goes wrong
- Fermented foods as a second, separate route
- Akkermansia, the mucus layer and an open contradiction
- What diversity on the plate means in practice
- What the German and the American guideline say
Abdominal complaints are almost always harmless. Some signs are not, and they need a medical work up before anything at all is changed about your diet.
- Blood in the stool or black, sticky, tarry stool
- Unintentional weight loss
- Fever without another explanation
- Complaints that wake you at night
- Repeated vomiting or difficulty swallowing
- A new, persistent change in bowel habit from around the age of 45 to 50
- Anaemia, meaning a documented low blood count
- Bowel cancer or inflammatory bowel disease in the family
These signs are not a case for a powder. They belong in prompt medical assessment. And no dietary change replaces or postpones a recommended colonoscopy, gastroscopy or laboratory work up.
Four terms that constantly get mixed up
Picture the shelf in the pharmacy. Four tubs side by side. One says probiotic, the next prebiotic, then synbiotic, then postbiotic.
The words sound like variants of the same product. They describe four completely different things, though, and the difference is not word play. It decides what you are actually holding.
The terms do not come from marketing. They come from ISAPP, an international expert body for probiotics and prebiotics that sets its definitions in consensus papers and revises them regularly.
Probiotics are the residents
Under the ISAPP consensus, a probiotic is defined as a live microorganism that confers a health benefit when administered in adequate amounts. Three conditions: alive, adequately dosed, with a documented benefit.
More on that is already in the cluster. Which capsule form survives the stomach passage better and what sets spore formers apart from classic strains is covered in Probiotics: spore form or capsule. Here we stay with the boundary.
Prebiotics are the food
The definition currently in force comes from the ISAPP consensus paper of 2017. A prebiotic is a substrate that is selectively utilised by host microorganisms and that confers a health benefit.
An expert panel from microbiology, nutrition science and clinical research met in December 2016 and reworked the prebiotic definition from the ground up.
What came out is a sentence with three load bearing words: substrate, selectively and documented benefit. What was new is that non carbohydrates also qualify and that the definition is not limited to the gut. The requirement for a selective, microbiota mediated mechanism stayed in place.
For you that means: prebiotic is not a marketing category, it is a hurdle with three steps. Anyone who merely claims that something feeds the good bacteria has not cleared that hurdle yet.
Gibson GR, Hutkins R, Sanders ME et al. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502. PMID: 28611480 · DOI: 10.1038/nrgastro.2017.75 [Guideline]Synbiotics are the combination, and there are two designs
Under the ISAPP paper of 2020, a synbiotic is a mixture of live microorganisms and substrates that are selectively utilised. The interesting part is the distinction inside it.
Complementary means: both parts meet their respective criteria on their own. A documented probiotic plus a documented prebiotic, each with its own data base, both together in one tub.
Synergistic means: the substrate was chosen specifically for the microorganisms it comes with. In that case it does not have to meet the individual criteria of a prebiotic, because it was never meant as a standalone prebiotic.
In practice that means: the word synbiotic on a pack does not yet tell you whether the components were matched to each other or merely placed side by side.
Postbiotics are what is left over
The ISAPP definition of 2021 reads: a preparation of inanimate microorganisms and their components that confers a health benefit. With or without metabolites.
There is a thinking error hidden here that turns up very often online.
Butyrate on its own is not a postbiotic under this definition. A pure metabolite without microbial cell components does not meet the criteria. Effective postbiotics have to contain inactivated cells or cell components.
That sounds like splitting hairs. But it is the difference between a substance and a preparation, and both sit on the shelf with the same label.
| Category | What it is | Example | Source |
|---|---|---|---|
| Probiotic | Live microorganisms, adequately dosed, with a documented benefit | Defined bacterial strains in capsule or spore form | Hill 2014, PMID 24912386 |
| Prebiotic | Substrate that is selectively utilised, with a documented benefit | Inulin, oligofructose, galactooligosaccharides | Gibson 2017, PMID 28611480 |
| Synbiotic | Mixture of live microbes and a selectively utilised substrate | Built complementary or synergistic | Swanson 2020, PMID 32826966 |
| Postbiotic | Preparation of inanimate microorganisms or their components | Heat inactivated bacteria, cell wall fragments | Salminen 2021, PMID 33948025 |
And now you know why four similar sounding tubs on the same shelf answer four different questions.
What separates a prebiotic from a dietary fibre
The next question follows almost automatically: is every dietary fibre a prebiotic, then?
The answer is no. And the reason is more interesting than it first sounds.
A dietary fibre is a definition from nutrition science: indigestible for our own enzymes. A prebiotic is a definition from microbiology: selectively utilisable by beneficial microorganisms, with a documented benefit.
The first says something about what we cannot do. The second says something about what they can do.
Wheat bran as the textbook case
Wheat bran is a classic dietary fibre. It binds water, increases stool bulk and speeds up transit. That is a physical effect, not a microbial one.
This is exactly where things get methodologically difficult, and the German S3 guideline on irritable bowel syndrome names it with remarkable openness.
Dietary fibres also have prebiotic properties, but not only that, since physical effects occur as well, among them an increase in stool bulk, so that it is unclear what the working principle is. They are therefore considered separately.
Paraphrased from the S3 guideline on irritable bowel syndrome, DGVS and DGNM, 2021 [Guideline]Translated: when a fibre is helpful, nobody knows for certain whether that comes from the fermentation or from the bulk. As long as that stays open, a prebiotic is hard to evaluate as a tool in its own right.
That is not a sign of ignorance. That is clean methodology, and it is the reason for the cautious guideline position we will look at more closely later.
Soluble beats insoluble
A group around Paul Moayyedi analysed 14 randomised trials with 906 people with irritable bowel syndrome in which dietary fibre was tested against placebo.
Overall a benefit appeared (RR 0.86; 95 % CI 0.80 to 0.94; NNT 10), but it lay exclusively with the soluble fibres (RR 0.83; NNT 7). For bran no effect was found, although no sign of harm either.
For you that means: the sentence more fibre is too crude. The type counts. Soluble and readily fermentable behaves differently from coarse and bulk forming.
Moayyedi P, Quigley EMM, Lacy BE et al. Am J Gastroenterol. 2014;109(9):1367-74. PMID: 25070054 · DOI: 10.1038/ajg.2014.195 [Meta-analysis, k=14, n=906]The question of amount, meaning the famous 30 grams a day, is already covered at length in Fibre: which myths hold up. Here we stay with the question of quality.
The two articles do not contradict each other, even if it sounds that way at first.
Dietary fibre is meant for the whole picture, prebiotics for a target group. One text says: do not treat the amount as a religion. This text says: take the selection seriously. Together they make one sentence. Not more substrate for everyone, but the right substrate for the gut you currently have.
And now you know why the question about the working principle matters more in this debate than any number of grams.
The substrates one by one: what each can do and how well it is studied
Now it gets concrete. Because prebiotic is an umbrella term for very different molecules, and their evidence base is spread very unevenly.
Some have been tested in dozens of trials. Some rest on a single dose finding study from industry. Both sit on the same shelf, often in the same price range.
One image first, to make the differences tangible: picture the colon as a long road. Some substrates are matchsticks. They burn immediately, right at the start of the road, with a lot of gas. Others are logs. They glow slowly and arrive further down.
Six substrates, three fermentation speeds
Inulin and oligofructose
Chicory, Jerusalem artichoke, globe artichoke, onion, leek
fastGalactooligosaccharides
Made from lactose, naturally present in pulses
fastResistant starch
Pulses, green banana, cooled potato and rice
slowPartially hydrolysed guar gum
From the guar bean seed, enzymatically shortened
slowAcacia fibre
Gum arabic, resin of the acacia tree
slowBeta glucans
Oats and barley, also in edible mushrooms
mediumThe speed given here is an orientation from fermentation research, not a measurement for an individual person. Rapidly fermentable means a lot of activity far forward in the colon. Slow means the fermentation reaches further back and spreads out.
Inulin and oligofructose: best studied, most often misunderstood
Inulin is the substance that opens almost every discussion about prebiotics. It sits in chicory root, in Jerusalem artichoke, in globe artichokes, in onions and leek. Oligofructose is the short chain version of it.
A team around Dávid Nagy systematically analysed randomised trials with at least seven days of intake, three databases plus two trial registries, with a Cochrane risk of bias assessment.
At study doses of 3 to 20 grams a day, chicory inulin type fructans clearly increased the number of bifidobacteria (SMD 0.83; 95 % CI 0.58 to 1.08; p < 0.01). The effect appeared in healthy people and in people with various conditions, with the exception of gastrointestinal disorders. Positive effects on bowel function were found only in healthy people.
For you that means: inulin can raise the number of bifidobacteria, and for a prebiotic that is an unusually solid data base. In the very people who reach for it because of gut complaints, though, the effect could not be shown.
Nagy DU, Sándor-Bajusz KA, Bódy B et al. Crit Rev Food Sci Nutr. 2023;63(33):12018-12035. PMID: 35833477 · DOI: 10.1080/10408398.2022.2098246 [Meta-analysis, k=50, n=2525]With constipation the picture looks a little friendlier, but here too a closer look pays off.
A Spanish group around Luis Collado Yurrita pooled five controlled trials with 252 participants on the effect of inulin in chronic constipation.
Stool frequency (SMD 0.69), stool consistency on the Bristol scale (SMD 1.07) and transit time (SMD -0.57) changed significantly for the better, and hard stool became less frequent (RR 0.42). Pain and flatulence did not improve.
For you that means: anyone reaching for inulin because of sluggish digestion has a data base. Anyone reaching for it because of a bloated belly is, according to this analysis, reaching for the wrong substrate.
Collado Yurrita L, San Mauro Martín I, Ciudad-Cabañas MJ et al. Nutr Hosp. 2014;30(2):244-52. PMID: 25208775 · DOI: 10.3305/nh.2014.30.2.7565 [Meta-analysis, k=5, n=252]Galactooligosaccharides: less was better
Galactooligosaccharides, GOS for short, are made from lactose and occur naturally in pulses. Breast milk contains a related group of compounds, which explains their popularity.
David Silk and colleagues tested three arms over twelve weeks in 44 people with irritable bowel syndrome by Rome II criteria: 3.5 grams of GOS a day, 7 grams of GOS a day and placebo.
Both GOS doses raised faecal bifidobacteria. At 3.5 grams, stool consistency, bloating, flatulence and the overall symptom score improved as well. At 7 grams only the global assessment was left of that.
For you that means: with prebiotics, more is not automatically better. In this trial the benefit partly reversed when the dose was doubled. These are study doses, not a recommendation.
Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR. Aliment Pharmacol Ther. 2009;29(5):508-18. PMID: 19053980 · DOI: 10.1111/j.1365-2036.2008.03911.x [RCT, n=44]Resistant starch: four types, a chapter of its own
Resistant starch is starch that reaches the small intestine undigested. The literature distinguishes four types, and that classification is established enough to describe here without an extra citation.
RS1 is physically enclosed, for instance in whole grains and seeds. RS2 sits in the natural granule structure, for example in green banana and raw potato. RS3 only forms when cooked starch cools down, which is retrogradation. RS4 is chemically modified and comes from food technology.
RS3 is the form that kitchens and forums argue about. It gets its own section shortly, because that is where most of the numbers circulate that nobody can document.
Partially hydrolysed guar gum: the quiet heavyweight
Hardly anyone knows it. In the irritable bowel literature it is nevertheless the best studied prebiotic substrate. It comes from the seed of the guar bean and is enzymatically shortened so that it no longer gels.
An Italian team around Giancarlo Parisi compared two arms over twelve weeks in 188 people with irritable bowel syndrome: 30 grams of wheat bran a day against 5 grams of partially hydrolysed guar gum a day. After four weeks participants were allowed to switch based on their own judgement.
Around 50 percent switched from the bran to the guar gum, but only about 11 percent in the other direction. In the intention to treat analysis the success rate was 60 versus 40 percent.
For you that means: six times less substrate, but the better balance. The amount is not the criterion, tolerability is. This is the very trial the German guideline cites in its fibre commentary.
Parisi GC, Zilli M, Miani MP et al. Dig Dis Sci. 2002;47(8):1697-704. PMID: 12184518 · DOI: 10.1023/a:1016419906546 [RCT, n=188]An important limitation: this trial was open label, so not blinded. The switching endpoint is vulnerable to expectation effects. It stands here anyway, because it asks an honest question, namely which substrate people voluntarily keep taking.
Zenta Yasukawa and colleagues gave 44 healthy adults with a tendency towards loose stool either partially hydrolysed guar gum or placebo over three months, double blind and in parallel groups, with microbiome analysis by 16S rRNA.
Stool form on the Bristol scale shifted clearly towards the middle under the guar gum, while stool frequency stayed unchanged. Individual bacterial genera shifted measurably.
For you that means: this substrate may push stool form towards the middle from both sides without driving frequency up. That is why it turns up both with a tendency to diarrhoea and with a tendency to constipation.
Yasukawa Z, Inoue R, Ozeki M et al. Nutrients. 2019;11(9):2170. PMID: 31509971 · DOI: 10.3390/nu11092170 [RCT, n=44]In children there is a signal pointing the same way, although from a pilot study: 60 children between 8 and 16 years with functional abdominal pain, four weeks, efficacy 43 versus 5 percent compared with placebo (Romano 2013, PMID 23345946). Thirty children per arm are too few for a strong statement. As a hint it still counts.
Acacia fibre: gentle in reputation, thin in evidence
Acacia fibre, that is gum arabic, is regarded in practice as particularly well tolerated. It earned that reputation over years. The study base behind it is modest.
Wim Calame and colleagues gave healthy volunteers 5, 10, 20 or 40 grams of gum arabic daily in water for up to four weeks, with water as a negative control and 10 grams of inulin as a positive control.
After four weeks bifidobacteria and lactobacilli were higher than in the negative control, with an optimum at around 10 grams a day. At that dose the counts were even above those under inulin.
For you that means: the effect on bacterial counts has been shown, a clinical endpoint has not. And the first author was employed by a manufacturer of the product under study. That does not devalue the data, but it belongs in the picture.
Calame W, Weseler AR, Viebke C, Flynn C, Siemensma AD. Br J Nutr. 2008;100(6):1269-75. PMID: 18466655 · DOI: 10.1017/S0007114508981447 [RCT]Beta glucans: the hardest clinical endpoint, only not in the gut
Beta glucans from oats and barley are soluble fibres that form a viscous layer in the small intestine and are fermented in the colon.
Erand Llanaj and colleagues systematically analysed 74 randomised trials with 4,937 predominantly hypercholesterolaemic or obese participants, 59 of them in the meta-analysis.
LDL cholesterol fell by 0.29 mmol/l (95 % CI -0.37 to -0.20), total cholesterol by 0.42 mmol/l, alongside smaller effects on glucose, weight and waist circumference. Studies on inflammatory markers were scarce and inconsistent, and 81 percent of the papers raised concerns about risk of bias.
For you that means: this is the hardest clinical endpoint in this whole substrate group. But it concerns blood lipids, not abdominal complaints. Anyone eating oats for the gut is relying on arguments other than these numbers.
Llanaj E, Dejanovic GM, Valido E et al. Eur J Nutr. 2022;61(4):1749-1778. PMID: 34977959 · DOI: 10.1007/s00394-021-02763-1 [Meta-analysis, k=59, n=4937]Oats and barley bring the gluten question with them. If coeliac disease is a possibility for you or has ever been suspected, one rule applies that often comes too late in everyday life: a gluten free diet before the diagnostic work up can make the coeliac diagnosis impossible, because antibodies and tissue findings may then turn out falsely negative.
So get tested first, change the diet afterwards. How the work up runs is described in Recognising coeliac disease.
Pectin and polyphenols: the two outliers
Pectin sits in apples, citrus peel and carrots and is undisputedly a soluble fibre. For this article I did not find a robust randomised trial with a clinical gut endpoint. So it stands here as a substrate, without a statement about effect. That is the honest version.
Polyphenols from tea, berries, grapes, cocoa and pomegranate are a special case. They are largely not absorbed in the small intestine and reach the colon, where bacteria transform them.
Xenofon Tzounis and colleagues gave 22 healthy volunteers 494 milligrams of cocoa flavanols a day against 23 milligrams for four weeks in a crossover design, with a washout phase and a switch.
Under the high dose, bifidobacteria and lactobacilli rose and clostridia decreased. In parallel, triglycerides and CRP fell, and the change in CRP was associated with the change in lactobacilli.
For you that means: polyphenols may shift the microbiome measurably. With 22 people that remains a hint. The correct expression is therefore prebiotic like, not a prebiotic under the ISAPP definition.
Tzounis X, Rodriguez-Mateos A, Vulevic J et al. Am J Clin Nutr. 2011;93(1):62-72. PMID: 21068351 · DOI: 10.3945/ajcn.110.000075 [RCT, n=22]A review from 2026 summarises the evidence on polyphenols and the microbiome and speaks explicitly of prebiotic like effects, while calling for further mechanistic and longitudinal studies (Rakhra 2026, PMID 41622499). That is exactly how it should be phrased.
| Substrate | Origin | Fermentation | Typical tolerability |
|---|---|---|---|
| Inulin, oligofructose | Chicory, Jerusalem artichoke, globe artichoke, onion, leek | fast, far forward in the colon | In a sensitive gut often more gas and tension |
| Galactooligosaccharides | From lactose, naturally in pulses | fast | In the trial the lower dose was the better tolerated one |
| Resistant starch (RS2, RS3) | Green banana, pulses, cooled potato and rice | slow, reaches further back | Usually quieter than inulin, still noticeable with marked overgrowth |
| Partially hydrolysed guar gum | Guar bean seed, enzymatically shortened | slow and even | In the comparative trial the clearly better tolerated substrate |
| Acacia fibre | Gum arabic, resin of the acacia tree | slow | Clinically regarded as gentle, study base thin |
| Beta glucans | Oats, barley, edible mushrooms | medium | Mostly fine, with a gluten question clarify diagnostics first |
| Pectin | Apple, citrus peel, carrot | medium | No robust trial on a gut symptom verified |
| Polyphenols | Tea, berries, grapes, cocoa, pomegranate | indirect, via bacterial transformation | As a rule unproblematic, evidence base small |
Bridgette Wilson and colleagues at King's College London screened 2,332 records and included 11 randomised trials with 729 people with irritable bowel syndrome or other functional bowel disorders.
On close inspection the picture split into two halves. Inulin type fructans made flatulence worse (SMD 0.85; 95 % CI 0.23 to 1.47; p = 0.007). Prebiotics that were not inulin type fructans improved it slightly (SMD -0.34; 95 % CI -0.66 to -0.01; p = 0.04), as did doses of 6 grams a day and below.
For you that means: if prebiotics give you flatulence, the obvious conclusion is often the wrong one. It can be down to the substrate type, not to an intolerance of fibre as such.
Wilson B, Rossi M, Dimidi E, Whelan K. Am J Clin Nutr. 2019;109(4):1098-1111. PMID: 30949662 · DOI: 10.1093/ajcn/nqy376 [Meta-analysis, k=11, n=729]The best selling substrate is not the best studied one for sensitive guts. That is not a scandal, it is market logic: inulin can be extracted cheaply from chicory root and tastes slightly sweet.
So the question is not whether prebiotics are any good. It is which one for which situation.
And now you know why two people with the same powder can have completely different experiences.
Resistant starch from the kitchen: what really forms on cooling
Hardly any nutrition tip has spread as fast as this one: boil potatoes, let them cool, eat them the next day. Resistant starch is said to form, and it is said to feed the gut.
The tip is right in principle. The numbers circulating online mostly are not.
What happens physically as it cools
During cooking the starch granules swell and lose their order. The chains lie loosely side by side and our amylases reach them easily.
As it cools, these chains rearrange and pack into dense crystalline regions. That process is called retrogradation. Picture woollen threads drifting chaotically in warm water and pulling together into a firm braid as they cool.
Our enzymes reach that braid less easily. The starch travels further back and lands with the bacteria. That is RS3.
An Indonesian team analysed three preparations of white rice and then tested them in a randomised, single blind crossover trial in 15 healthy adults.
Resistant starch content was 0.64 grams per 100 grams for freshly cooked rice, 1.30 grams after 10 hours at room temperature and 1.65 grams after 24 hours at 4 degrees with subsequent reheating. The chilled and reheated version lowered the blood glucose response significantly (125 versus 152 mmol·min/l; p = 0.047).
For you that means two things. Reheating does not destroy the resistant starch, on the contrary, that version had the highest content. And 1.65 grams per 100 grams is a small amount. Expectations should match that.
Sonia S, Witjaksono F, Ridwan R. Asia Pac J Clin Nutr. 2015;24(4):620-5. PMID: 26693746 [RCT, n=15]Two numbers that are everywhere and documented nowhere
Two figures keep turning up on health insurer pages, advice portals and magazine sites. For neither of them did I find a traceable primary study.
The first is the twelve hour rule, according to which resistant starch forms after about twelve hours. What is documented are the values above: 10 hours at room temperature and 24 hours in the fridge, with different results. A clean threshold at twelve hours is not what the data give.
The second is the claim that cooled potatoes have 3.5 kilocalories less per 100 grams. No primary source could be found for that either. I list it here only in order to explicitly not adopt it.
And what does that do to the gut?
This is where it gets interesting, because the most honest study on the whole topic carries a small disappointment.
Peter DeMartino and colleagues had 50 participants in a randomised crossover feeding trial eat a potato side dish daily, compared with a calorie matched side dish made from refined grain.
The potato dishes contained more resistant starch (1.31 versus 0.73 percent; p = 0.03). Butyrate producers increased, alpha diversity dropped slightly. Faecal butyrate stayed unchanged.
For you that means: one portion a day may shift the microbiome measurably. The hoped for rise in butyrate in the stool did not appear, though. Anyone promising more here is going beyond the data.
DeMartino P, Johnston EA, Petersen KS, Kris-Etherton PM, Cockburn DW. Nutrients. 2022;14(3):721. PMID: 35277080 · DOI: 10.3390/nu14030721 [RCT, n=50]Why faecal butyrate is a poor messenger
Measuring butyrate in the stool is about as informative as measuring petrol in the exhaust pipe to work out how far a car has driven.
Most of the butyrate produced is taken up and burned directly by the colon cells before the stool leaves the body. An unchanged stool value can therefore mean that nothing was produced. It can just as well mean that everything produced was consumed straight away.
So the DeMartino finding is not proof against resistant starch. It is evidence that the marker chosen cannot answer the question. This distinction is missing from almost every summary of that study.
Cooled starch may lower the blood glucose response. That is exactly what can become an issue with ongoing insulin therapy.
In a crossover trial in 32 people with type 1 diabetes, the glucose peak (9.9 versus 11 mmol/l; p = 0.0056) and the area under the curve (135 versus 336 mmol/l·180 min; p < 0.0001) were considerably lower after chilled and reheated rice. At the same time significantly more hypoglycaemic episodes occurred, 12 versus 3 (p = 0.0039), at an unchanged insulin dose.
If you inject insulin or take blood glucose lowering medication, a dietary change like this belongs in a conversation with your doctor beforehand and needs medical follow up afterwards. Ongoing medication is never altered on your own, neither in dose nor in timing.
Strozyk S, Rogowicz-Frontczak A, Pilacinski S et al. Nutr Diabetes. 2022;12(1):21. PMID: 35429987 · DOI: 10.1038/s41387-022-00196-1 [RCT, n=32]
And now you know why yesterday's potato salad remains a good idea but is not a therapy.
What comes out of it: butyrate, propionate, acetate
Up to here it was about the food. Now it is about what the bacteria make from it.
When microorganisms ferment fibres, short chain fatty acids are produced. Above all three: acetate, propionate and butyrate. Acetate mostly goes into the bloodstream, propionate is processed further in the liver, and butyrate largely stays on site.
Butyrate is therefore the substance that gets the most attention. The reason for that comes from a paper carried out in a mouse model.
Dallas Donohoe and colleagues compared germ free and conventionally colonised mice using metabolomics, gene expression and experiments on isolated colon cells.
The colon cells of germ free mice were in an energy shortage: less NADH relative to NAD+, less oxidative phosphorylation, less ATP. That activated AMPK and led to autophagy. Adding butyrate brought mitochondrial respiration back up, and it did so through its role as an energy source rather than through inhibition of histone deacetylases.
For you that means: the phrase butyrate is the main fuel of the colon cells is not a metaphor, it was shown experimentally. But in the mouse model. In humans it is plausible and not documented with the same clarity.
Donohoe DR, Garge N, Zhang X et al. Cell Metab. 2011;13(5):517-26. PMID: 21531334 · DOI: 10.1016/j.cmet.2011.02.018 [In vivo, mouse]Everything else about butyrate, the mucosa and the supplement questions is covered at length in L-glutamine and butyrate for the gut lining. Here it is only about the path from substrate to metabolite.
Not everyone makes the same thing from the same food
A team around Liping Zhao studied people with type 2 diabetes on purpose built, calorie matched diets and analysed the faecal microbiome in parallel by shotgun metagenomics.
Fibres selectively promoted a particular group of short chain fatty acid producers, while most other potential producers stayed the same or declined. Those with more of these promoted strains showed the stronger improvement in HbA1c, partly via more GLP-1. Producers of unfavourable products such as indole and hydrogen sulphide decreased.
For you that means: fibre feeds the microbiome is too crude a phrase. It feeds particular strains. And whether you have them, nobody knows in advance.
Zhao L, Zhang F, Ding X et al. Science. 2018;359(6380):1151-1156. PMID: 29590046 · DOI: 10.1126/science.aao5774 [RCT]An observation from a Dutch paper that tested two fibre mixtures against single substrates fits with this.
Emanuel Canfora and colleagues first selected fibre mixtures with high acetate production in the distal colon using a colon model, then tested them in two randomised crossover trials in lean men and in prediabetic men with overweight.
Long chain inulin plus resistant starch raised plasma acetate in the prediabetic group compared with inulin alone and placebo. In the lean participants, breath hydrogen and fasting butyrate rose, accompanied by higher energy expenditure, higher PYY and lower post meal glucose values. Microbiome responses varied greatly between individuals.
For you that means: a mixture of rapidly and slowly fermentable fibres may reach the distal colon better than a single substrate. And the effect depended on the metabolic type. This is the best available evidence that there is no substrate that suits everyone.
Canfora EE, Hermes GDA, Müller M et al. Gut Microbes. 2022;14(1):2009297. PMID: 34923911 · DOI: 10.1080/19490976.2021.2009297 [RCT]A prebiotic is not a nutrient for you. It is an offer to a community you do not know. What comes of it is decided not by the packaging but by the line up in your colon.
And now you know why the same fibre can feed two different metabolic routes in two people.
Why prebiotics make things worse for some people at first
Now comes the section this article hangs on.
Because the most common feedback on prebiotic powders is not I feel better. It is: at the start it was worse, and at some point I dropped it.
Two explanations for that circulate online. One says: that is an initial worsening, you have to push through. The other says: you are feeding your overgrowth.
The first explanation is not documented. The second is plausible but likewise not cleanly documented. What has actually been measured is a third thing, and it is more interesting than either.
What the largest analysis shows
The same analysis from London that showed the substrate difference also looked at the overall effect: prebiotics against placebo in adults with irritable bowel syndrome and other functional bowel disorders.
52 of 97 people on prebiotics counted as responders (54 percent) and 59 of 94 on placebo (63 percent). No difference emerged (OR 0.62; 95 % CI 0.07 to 5.69; p = 0.67). Nothing showed up for abdominal pain, bloating or quality of life either. Bifidobacteria did rise measurably. None of the included trials had a low risk in all bias categories.
For you that means: the microbiome shifted, the complaints did not. A changed microbiome is simply not a symptom benefit, and that is a sentence that hardly ever appears in an advertisement.
Wilson B, Rossi M, Dimidi E, Whelan K. Am J Clin Nutr. 2019;109(4):1098-1111. PMID: 30949662 · DOI: 10.1093/ajcn/nqy376 [Meta-analysis, k=11, n=729]The second large analysis did not even arrive at a number for prebiotics.
Alexander Ford and colleagues searched MEDLINE, EMBASE and Cochrane for randomised trials on prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome and screened 4,017 citations for that.
For probiotics, 53 trials with 5,545 patients could be analysed. For prebiotics and synbiotics the authors stated in so many words that the evidence was sparse.
For you that means: there is no shortage of opinions, there is a shortage of studies. And that is exactly what the German guideline rests on.
Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Aliment Pharmacol Ther. 2018;48(10):1044-1060. PMID: 30294792 · DOI: 10.1111/apt.15001 [Meta-analysis]The measured mechanism: not more gas, more sensation
A British team around Giles Major gave 29 people with irritable bowel syndrome and bloating plus 29 healthy comparison participants 500 millilitres of a drink containing 40 grams of carbohydrate on three occasions: once glucose, once fructose, once inulin. Measurement was by breath hydrogen and by MRI of the bowel contents.
Inulin increased colonic volume and colonic gas in both groups. The MRI values and breath hydrogen did not differ substantially between the irritable bowel group and healthy controls, but the symptom scores did. 13 of 29 people with irritable bowel syndrome reached the symptom threshold after inulin, after glucose only 6.
For you that means: in this study the belly did not produce more gas than anyone else's. It reported it more loudly. So what matters may be the sensitivity of the bowel wall rather than the amount of gas.
Major G, Pritchard S, Murray K et al. Gastroenterology. 2017;152(1):124-133.e2. PMID: 27746233 · DOI: 10.1053/j.gastro.2016.09.062 [RCT, n=58]How this heightened sensitivity develops and what may influence it is covered in Irritable bowel: the search for causes. Here the mechanism is enough.
Initial worsening is not a documented concept
The phrase you have to push through sounds like patience and consistency. In this field it has no data behind it. There is no study showing that a worsening under prebiotics is a transitional stage on the way to something better.
What exists instead: a measured sensitivity threshold that is reached earlier after inulin than after glucose, and a substrate that made flatulence measurably worse in the meta-analysis.
Complaints under a powder are therefore not a moral test. They are information about substrate, amount or timing.
The order: why building up before calming down often goes wrong
In my view this is the practically most important point of the whole topic.
Many people start with the building up part, because it sounds like the right idea. Do not suppress, nourish. Do not take away, give.
That is a good attitude. It is just the second question here, not the first.
If there are too many bacteria in the small intestine, if methane producers are slowing transit, or if the bowel wall overreacts to normal stretch, then a rapidly fermentable substrate meets the least favourable possible starting point. It gets processed at the front, where it does not belong, or it arrives in a belly that already reports every small change in volume.
So the order here may decide more than the amount.
An order that holds up on both sides
First the safety question
Rule out red flags, attend the recommended assessments. No build up concept replaces a colonoscopy, a coeliac serology or a faecal calprotectin.
Red flagsBasic diagnosticsThen the question of what is going on
Is bacterial overgrowth a possibility, a methane constellation, a marked sensitivity of the bowel wall, a bile acid issue? These are different situations with different consequences.
Clarify the situationmedically supervisedThen the question about the top end
In my practice I ask before anything else whether enough acid is arriving in the stomach at all. Digestive enzymes come after that question for me, not before it.
Important alongside this: if you already take an acid blocker, this is not an invitation to stop or reduce it. The same applies to laxatives, to antibiotics and to immunosuppressive therapies. These medicines have their reasons, and abrupt discontinuation can carry risks of its own. Whether, when and how anything changes there belongs in the hands of the doctor who prescribed them. Please make changes only after discussing them with your doctor and with medical follow up, never on your own.
Stomach acid firstOnly then the choice of substrate
And by tolerability, not by amount. The evidence suggests that in a sensitive gut, slowly fermentable substrates without inulin type fructans are the quieter choice.
Selection before amountFinally the breadth
Once the belly is quieter, a powder turns back into a plate. Diversity instead of a single substrate, because different substrates can reach different strains.
Diversity instead of amountThis is deliberately a direction and not a plan with week numbers. What fits at what pace depends on the findings and belongs in a medical consultation, not in a blog article.
There is a separate text on the stomach acid question: Low stomach acid and betaine HCl. On the situations from step 2 you will find SIBO in the small intestine, IMO and methanogens and Bile and bile acids. And if it is about leaving something out for a limited period, the approach is described in Using FODMAP properly.
And what about SIBO?
The honest answer is unsatisfying. There are no robust studies on prebiotics in bacterial overgrowth. And even the diagnostic work up is methodologically contested.
Chu Yao and Caroline Tuck summarised the evidence on hydrogen breath tests in functional bowel disorders: methodology, interpretation, reproducibility, symptom correlation.
They describe wide differences in test parameters and cut off values, poor reproducibility on repeat testing with fructose and lactulose, and a weak correlation between symptoms during the test and actual malabsorption. They classify a SIBO diagnosis based on a lactulose breath test as unreliable.
For you that means: if a text says that prebiotics belong later with SIBO, the same text also has to say that the diagnosis itself does not stand on firm ground. Both belong together.
Yao CK, Tuck CJ. J Gastroenterol Hepatol. 2017;32 Suppl 1:20-22. PMID: 28244675 · DOI: 10.1111/jgh.13689 [Mechanism Review]A second review arrives independently at the same caution: cumulative hydrogen production after lactulose was no higher in people with irritable bowel syndrome than in controls (Yao 2018, PMID 29035975). More gas is simply not automatically more complaint.
What the professional societies say, and why
- German S3 guideline on irritable bowel syndrome, DGVS and DGNM, 2021, recommendation 7-3
- No recommendation can be given for prebiotics in the treatment of irritable bowel syndrome. Recommendation grade 0, consensus.
- The reasoning in the commentary
- The most frequently studied prebiotic is inulin, and the attempt at a meta-analysis on prebiotic therapy in irritable bowel syndrome failed in 2014 for lack of evidence. Alongside that the methodological argument: with dietary fibres it cannot be separated whether the benefit comes from the fermentation or from the stool bulk.
- What the same guideline does recommend
- In adults with irritable bowel syndrome and predominantly constipation type complaints, dietary fibres should be used, preferably soluble ones. Recommendation grade B, strong consensus. The commentary also states that one should start with low doses and increase carefully according to tolerability.
- ACG Clinical Guideline, USA, 2021
- Prebiotics do not appear as a separate recommended intervention. What is recommended includes a positive diagnostic strategy rather than pure exclusion, coeliac serology and faecal calprotectin with diarrhoea symptoms, and a time limited low FODMAP trial.
- And how I read that
- No recommendation possible does not mean useless. It means not sufficiently documented for a guideline statement. That caution is methodologically clean and not ideological, and I consider it a good standard. The functional perspective asks a different question, namely what a substrate does to the microbiome and how that can be classified. That question does not answer the guideline question, and it does not replace it either.
Layer P, Andresen V, Allescher H et al. Z Gastroenterol. 2021;59(12):1323-1415. PMID: 34891206 · DOI: 10.1055/a-1591-4794 [Guideline] · Lacy BE, Pimentel M, Brenner DM et al. Am J Gastroenterol. 2021;116(1):17-44. PMID: 33315591 · DOI: 10.14309/ajg.0000000000001036 [Guideline]
An overview from 2025 covering 58 meta-analyses on eleven dietary interventions in irritable bowel syndrome classifies this similarly: most effects were small and the certainty of evidence under GRADE was low to very low. Moderate certainty was found only for abdominal pain under probiotics and for symptoms under a low FODMAP approach (Zeraattalab-Motlagh 2025, PMID 39110917).
Gastroenterology is not the brake here. It asks a different question from nutritional medicine, and its answer is consistent.
What follows from both perspectives together is not giving up on prebiotics, but an order. Safety first, then the situation, then the substrate. Not the other way round.
And now you know why the same spoonful of powder can lead to three very different evenings in three people.
Fermented foods: the second route
There is a second route to the microbiome, and it does not run through a powder but through a jar in the fridge.
Sauerkraut, kimchi, kefir, yoghurt, miso, tempeh, kombucha. These foods are created through intentional microbial growth and enzymatic conversion. That is how the ISAPP consensus paper of 2021 defines them (Marco 2021, PMID 33398112).
What matters is the boundary that the same paper sharpens explicitly: a fermented food is not a probiotic. Sauerkraut contains microorganisms, but without a defined strain, without a defined dose, without a documented benefit for that particular strain.
That is not a put down. It is a category of its own, and it has one of the most interesting studies of recent years on its side.
A team around Hannah Wastyk and Justin Sonnenburg at Stanford University compared two microbiota targeted diets in healthy adults over 17 weeks, 18 people per group: plant based and high in fibre against fermented foods. Measurement was by microbiome sequencing and extensive immune profiling.
Under the fermented foods, microbiome diversity rose steadily and inflammatory markers went down. Under the high fibre diet, diversity stayed stable while the number of microbial enzymes that break down glycans increased. Within that group three different immune trajectories appeared, which were related to diversity at baseline. The primary endpoint, a cytokine response score, did not change in either group.
For you that means: the shortened headline fermented beats fibre is not what the study gives. The fibre group upgraded its microbiome enzymatically. Only diversity did not rise in that time window. That is a finding about the period, not about a lack of effect.
Wastyk HC, Fragiadakis GK, Perelman D et al. Cell. 2021;184(16):4137-4153.e14. PMID: 34256014 · DOI: 10.1016/j.cell.2021.06.019 [RCT, n=36]Honesty requires this too: 18 people per group is a small sample, all were healthy, and the endpoints were surrogate markers. No transfer to people with bowel disease can be drawn from that.
Fermented foods and fibres are not competitors, they are two different levers.
One brings microorganisms and their metabolites with it. The other brings food for those already there. In the Stanford study something happened in both groups, just something different.
Fermented foods are often rich in biogenic amines, histamine among them. With known histamine intolerance or with mast cell issues they can therefore trigger exactly the complaints you wanted to avoid.
That belongs checked before sauerkraut becomes a daily recommendation. More on this in Histamine intolerance and DAO deficiency and in MCAS and mast cell activation.
And now you know why the jar in the fridge deserves a category of its own and is not a replacement for the plate.
Akkermansia muciniphila and the mucus layer
One name has been turning up everywhere in microbiome discussions for some years now: Akkermansia muciniphila. The second part of the name means mucus loving, and that describes it well.
This bacterium does not live in the middle of the bowel contents but in the mucus layer that covers the intestinal epithelium. It feeds on mucin, meaning on that very mucus.
At first that sounds the wrong way round. A bacterium that eats our protective layer is supposed to be useful? The explanation may lie in the balance: moderate mucin breakdown can stimulate new production, so the layer stays in motion and stays dense. Only when too many mucus eaters find too little other food can the ratio tip.
Mahesh Desai and colleagues colonised germ free mice with a defined human gut flora of fully sequenced commensals and exposed them to chronic or intermittent fibre deprivation.
Under sustained deprivation the microbiome switched to host mucin as a food source. The mucus layer of the colon became thinner. Together with a mucus degrading flora, fibre deprivation promoted access to the epithelium and a lethal course of colitis caused by the mucosal pathogen Citrobacter rodentium.
For you that means: this is the mechanism behind the image of a microbiome that helps itself to the host when nothing else arrives. It comes from the mouse model. But it makes a good case for why a permanently low fibre exclusion diet is not a good end state.
Desai MS, Seekatz AM, Koropatkin NM et al. Cell. 2016;167(5):1339-1353.e21. PMID: 27863247 · DOI: 10.1016/j.cell.2016.10.043 [In vivo, mouse]How closely the mucus layer and barrier function are linked is covered at length in Leaky gut, intestinal permeability and zonulin.
The contradiction I am not smoothing over
Now comes the point where the evidence gets uncomfortable.
Amandine Everard and colleagues tested live and heat inactivated Akkermansia muciniphila in mouse models of obesity and type 2 diabetes.
In obese and diabetic mice the abundance was reduced. Prebiotic feeding brought it back towards baseline, accompanied by a more favourable metabolic profile. Giving the live bacterium reversed several consequences of a high fat diet. Heat inactivated cells showed no effect on the metabolic profile or on the thickness of the mucus layer.
For you that means: the genuinely interesting finding is not the administration of the bacterium but the feeding. Prebiotic substrates changed the abundance without any bacterium being swallowed.
Everard A, Belzer C, Geurts L et al. Proc Natl Acad Sci U S A. 2013;110(22):9066-71. PMID: 23671105 · DOI: 10.1073/pnas.1219451110 [In vivo, mouse]Clara Depommier and colleagues gave volunteers with overweight to obesity and insulin resistance daily Akkermansia muciniphila for three months, either live or pasteurised, against placebo. 40 people were enrolled, 32 completed.
Administration was safe and well tolerated. Several values improved only under the pasteurised bacterium, though: insulin sensitivity plus 28.6 percent (p = 0.002), insulinaemia minus 34.1 percent (p = 0.006), total cholesterol minus 8.7 percent (p = 0.02). Body weight and fat mass showed trends only. The overall structure of the microbiome stayed unchanged.
For you that means: 32 people, exploratory, no clinical endpoints. And an open contradiction with the animal model that I will leave standing here: in the mouse only the live bacterium showed an effect, in humans only the pasteurised one. Anyone deriving a purchase recommendation from that is going far beyond the data.
Depommier C, Everard A, Druart C et al. Nat Med. 2019;25(7):1096-1103. PMID: 31263284 · DOI: 10.1038/s41591-019-0495-2 [RCT, n=32]Three levels, cleanly separated
Documented by meta-analyses and randomised trials: inulin type fructans may raise bifidobacteria and may make flatulence worse in a sensitive gut. Soluble fibres performed better than insoluble ones in irritable bowel syndrome. Beta glucans may lower LDL cholesterol.
Mechanistically plausible, human studies thin: butyrate as the main fuel of the colon cells, the link between low fibre intake and the mucus layer, the role of Akkermansia and the classification of acacia fibre and polyphenols.
What I observe clinically: that people with marked sensitivity tolerate slowly fermentable substrates more quietly than fast ones, and that the order decides more than the amount. That is an observation from the consultation room and not a study result.
And now you know why the most discussed gut bacterium of recent years is not an argument for a capsule but one for the plate.
Diversity on the plate: what that means in practice
That leaves the question everyone asks in the end: so what do I eat?
I am deliberately not giving you a number of weeks or a target amount. Not out of reticence, but because the data do not support it.
The argument for that is already above. Fibres do not promote the microbiome in general, they promote particular strains. Those who have them might benefit more. Those who do not, less. And nobody knows in advance which line up sits in your colon.
From that follows no numerical target but a strategy: breadth instead of amount. Different substrates can reach different strains and different sections of the colon.
Where the substrate classes sit in everyday food
- Inulin and oligofructose: chicory, Jerusalem artichoke, globe artichoke, onion, leek, garlic, salsify.
- Galactooligosaccharides: lentils, chickpeas, beans, peas.
- Resistant starch: cooled potatoes and rice, pulses, green bananas, wholegrain with the grain intact.
- Beta glucans: oats, barley, edible mushrooms. If coeliac disease is a possibility: diagnostics first, diet second, because a gluten free diet before the work up can make the diagnosis impossible.
- Pectin: apples, carrots, citrus peel, quinces.
- Mucilages and gums: flaxseed, psyllium husk, guar gum.
- Polyphenols as indirect substrates: berries, grapes, pomegranate, dark cocoa, green tea, olive oil, herbs.
- Fermented foods as a separate route: sauerkraut, kimchi, kefir, yoghurt, miso, tempeh.
That is not a plan. That is a map. How much of it fits in which phase is an individual question.
Two things matter to me here.
First: the framework stays the same. Safety and assessment first, then the question of the situation, then selection and breadth. Turning that order around can make things unnecessarily hard, and the belly often joins in.
Second: a permanently low fibre diet is not a goal, at most a way station. The animal data on the mucus layer are an argument for keeping the road back to breadth open. The ACG guideline also stresses explicitly that a restrictive approach should stay time limited.
If you want to read on: the question of amount is covered in Fibre: which myths hold up, the question of inflammation promoting patterns in Inflammatory foods, and how much sleep and rhythm play into this in Sleep and the microbiome.
Not prebiotics for everyone. Rather the right substrate, at the right time, for the gut you currently have. That is less catchy than a number of grams. But it is what the data support.
And now you know why diversity is the most honest recommendation this field allows to be drawn from the evidence.
Common questions about prebiotics and resistant starch
What is the difference between prebiotics and probiotics?
Probiotics are live microorganisms that may confer a health benefit when given in adequate amounts. Prebiotics are substrates that are selectively utilised by your own microorganisms and that bring a documented benefit. Put simply: one is the residents, the other is their food. Both definitions come from ISAPP, an international expert body for probiotics and prebiotics (Hill 2014, PMID 24912386; Gibson 2017, PMID 28611480).
Are all dietary fibres prebiotics?
No. Under the ISAPP definition a substrate has to be selectively utilised by beneficial microorganisms and show a documented health benefit. Wheat bran, for example, works mainly through stool bulk, which is a physical effect. The German S3 guideline on irritable bowel syndrome names exactly this problem: with dietary fibres it is unclear what the working principle is, because physical effects occur alongside fermentation.
What are synbiotics and what are postbiotics?
According to ISAPP a synbiotic is a mixture of live microorganisms and substrates that are selectively utilised. There are two designs: complementary, meaning a probiotic plus a prebiotic that each meet the criteria on their own, and synergistic, where the substrate is tailored to the microorganisms it comes with. Postbiotics are preparations of inactivated microorganisms or their components. One important detail: butyrate on its own does not meet that definition, because a pure metabolite without cell components falls outside it (Swanson 2020, PMID 32826966; Salminen 2021, PMID 33948025).
Which prebiotic is best studied in a sensitive gut?
Based on the available data, partially hydrolysed guar gum. In an open trial in 188 people with irritable bowel syndrome, 5 grams a day were compared with 30 grams of wheat bran. In the intention to treat analysis the success rate was 60 versus 40 percent, and far more people switched from the bran to the guar gum than the other way round (Parisi 2002, PMID 12184518). Those are study doses from the literature and not a recommendation for you.
Why does inulin give me flatulence?
In a meta-analysis of 11 randomised trials with 729 people, inulin type fructans made flatulence measurably worse (SMD 0.85; 95 percent confidence interval 0.23 to 1.47; p = 0.007), while prebiotics without inulin improved it slightly (Wilson 2019, PMID 30949662). An MRI study showed a possible mechanism: after 40 grams of inulin, people with irritable bowel syndrome did not produce more gas than healthy controls, yet reported symptoms far more often (Major 2017, PMID 27746233). So it can be down to the substrate rather than the amount.
How much resistant starch is created when I cool rice or potatoes?
In an Indonesian analysis, freshly cooked white rice contained 0.64 grams of resistant starch per 100 grams. After 10 hours at room temperature it was 1.30 grams, and after 24 hours at 4 degrees with subsequent reheating it was 1.65 grams (PMID 26693746). That is genuinely measurable and at the same time a small amount. The twelve hour rule that circulates online does not come from any traceable primary study.
Does reheating destroy the resistant starch?
Not in that analysis. The version that spent 24 hours in the fridge and was then reheated had the highest content at 1.65 grams per 100 grams, and it lowered the blood glucose response significantly compared with fresh rice (125 versus 152 mmol·min/l; p = 0.047; PMID 26693746). Retrogradation, meaning the recrystallisation of starch as it cools, largely survives reheating.
Is cooled starch an issue for people with diabetes?
Yes, in both directions. In a crossover trial in 32 people with type 1 diabetes, the glucose peak after cooled rice was lower and the area under the curve was considerably smaller. At the same time significantly more hypoglycaemic episodes occurred, 12 versus 3, at an unchanged insulin dose (Strozyk 2022, PMID 35429987). If you take insulin or blood glucose lowering medication, a change like this belongs in a conversation with your doctor and needs medical follow up. Ongoing medication is never altered on your own.
How long does it take before anything changes?
The honest answer: the studies cited here ran between four and seventeen weeks, and most endpoints were surrogate markers such as bacterial counts rather than symptoms. Stool form and tolerability shifted within a few weeks, microbiome diversity later or not at all. No promise about a particular point in time can be drawn from that.
What are short chain fatty acids and why is butyrate mentioned so often?
Short chain fatty acids are produced when gut bacteria ferment fibres, above all acetate, propionate and butyrate. In a mouse model, butyrate turned out to be the preferred energy source of the colon cells: colonocytes of germ free mice were in an energy deficit, and adding butyrate brought mitochondrial respiration back up (Donohoe 2011, PMID 21531334). In humans this link is plausible but has not been shown with the same clarity.
Prebiotics with SIBO, yes or no?
There are no robust studies on this, and even the diagnostic work up is methodologically contested: hydrogen breath tests show poor reproducibility and a weak correlation with symptoms (Yao 2017, PMID 28244675). What the data do show: in a sensitive gut, inulin type fructans made flatulence worse, while low dose substrates without inulin tended to improve it (Wilson 2019, PMID 30949662). So it makes sense to first clarify what is going on in the gut and to choose the substrate accordingly. That belongs in medical care.
Fermented foods or dietary fibre, which is better?
The Stanford study with 18 people per group over 17 weeks found a steadily rising microbiome diversity and a drop in inflammatory markers under fermented foods. That did not make the high fibre group the losers: their microbiome built up more glycan degrading enzymes, and three different immune trajectories appeared depending on baseline diversity. The primary endpoint, a cytokine response score, did not change (Wastyk 2021, PMID 34256014). That speaks for two routes, not for one winner.
What is Akkermansia muciniphila, and should I be swallowing it?
Akkermansia muciniphila lives in the mucus layer of the gut and feeds on mucin. In an exploratory pilot study in 32 people with overweight, the pasteurised bacterium improved insulin sensitivity over three months, the live one did not (Depommier 2019, PMID 31263284). In the mouse model it was the other way round, there only the live bacterium showed an effect (Everard 2013, PMID 23671105). That contradiction is unresolved. The data are too thin for a recommendation. The more interesting finding is that prebiotic feeding brought the abundance back towards baseline in the animal model anyway.
What do the medical guidelines say about prebiotics?
The German S3 guideline on irritable bowel syndrome states in recommendation 7-3 that no recommendation can be given for prebiotics in the treatment of irritable bowel syndrome. The reasons given are the thin evidence base and the fact that fermentation and stool bulk cannot be cleanly separated with fibres (Layer 2021, PMID 34891206). The American ACG guideline likewise does not list prebiotics as a separate intervention (Lacy 2021, PMID 33315591). No recommendation possible does not mean useless, it means not sufficiently documented for a guideline statement.
Where this topic connects to the rest of the body
What gets fermented in the colon does not stay in the colon. It is tied to the mucosa, to the immune system, to the nervous system and to the question of how well nutrients arrive at all.
Fibre myths
The question of amount, the famous 30 and what holds up
L-glutamine and butyrate
What fermentation produces and what the gut lining needs
Sleep and the microbiome
Why rhythm changes more in the gut than most people think
Gut brain axis
The vagus as the line between gut feeling and head
Histamine intolerance
When fermented foods are exactly the wrong thing
Inflammatory foods
Which patterns on the plate tend to promote inflammation
Paleo and AIP
Exclusion approaches, their strengths and their time limit
Iron deficiency and the gut
Why absorption problems in the gut are often the overlooked part
Scientific sources
- Gibson GR, Hutkins R, Sanders ME et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502. PMID: 28611480 · DOI: 10.1038/nrgastro.2017.75 [Guideline]
- Hill C, Guarner F, Reid G et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14. PMID: 24912386 · DOI: 10.1038/nrgastro.2014.66 [Guideline]
- Swanson KS, Gibson GR, Hutkins R et al. The ISAPP consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17(11):687-701. PMID: 32826966 · DOI: 10.1038/s41575-020-0344-2 [Guideline]
- Salminen S, Collado MC, Endo A et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667. PMID: 33948025 · DOI: 10.1038/s41575-021-00440-6 [Guideline]
- Marco ML, Sanders ME, Gänzle M et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods. Nat Rev Gastroenterol Hepatol. 2021;18(3):196-208. PMID: 33398112 · DOI: 10.1038/s41575-020-00390-5 [Guideline]
- Layer P, Andresen V, Allescher H et al. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der DGVS und der DGNM. Z Gastroenterol. 2021;59(12):1323-1415. AWMF 021/016. PMID: 34891206 · DOI: 10.1055/a-1591-4794 [Guideline]
- Lacy BE, Pimentel M, Brenner DM et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44. PMID: 33315591 · DOI: 10.14309/ajg.0000000000001036 [Guideline]
- Nagy DU, Sándor-Bajusz KA, Bódy B et al. Effect of chicory-derived inulin-type fructans on abundance of Bifidobacterium and on bowel function: a systematic review with meta-analyses. Crit Rev Food Sci Nutr. 2023;63(33):12018-12035. PMID: 35833477 · DOI: 10.1080/10408398.2022.2098246 [Meta-analysis, k=50, n=2525]
- Collado Yurrita L, San Mauro Martín I, Ciudad-Cabañas MJ et al. Effectiveness of inulin intake on indicators of chronic constipation: a meta-analysis of controlled randomized clinical trials. Nutr Hosp. 2014;30(2):244-52. PMID: 25208775 · DOI: 10.3305/nh.2014.30.2.7565 [Meta-analysis, k=5, n=252]
- Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508-18. PMID: 19053980 · DOI: 10.1111/j.1365-2036.2008.03911.x [RCT, n=44]
- Parisi GC, Zilli M, Miani MP et al. High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci. 2002;47(8):1697-704. PMID: 12184518 · DOI: 10.1023/a:1016419906546 [RCT, n=188]
- Yasukawa Z, Inoue R, Ozeki M et al. Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial. Nutrients. 2019;11(9):2170. PMID: 31509971 · DOI: 10.3390/nu11092170 [RCT, n=44]
- Romano C, Comito D, Famiani A, Calamarà S, Loddo I. Partially hydrolyzed guar gum in pediatric functional abdominal pain. World J Gastroenterol. 2013;19(2):235-40. PMID: 23345946 · DOI: 10.3748/wjg.v19.i2.235 [RCT, n=60]
- Calame W, Weseler AR, Viebke C, Flynn C, Siemensma AD. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner. Br J Nutr. 2008;100(6):1269-75. PMID: 18466655 · DOI: 10.1017/S0007114508981447 [RCT]
- Llanaj E, Dejanovic GM, Valido E et al. Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. 2022;61(4):1749-1778. PMID: 34977959 · DOI: 10.1007/s00394-021-02763-1 [Meta-analysis, k=59, n=4937]
- Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JPE. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr. 2011;93(1):62-72. PMID: 21068351 · DOI: 10.3945/ajcn.110.000075 [RCT, n=22]
- Rakhra G, Malhotra R, Prasad P et al. Synergistic Effects of Polyphenols and Gut Microbiota-Derived Metabolites on Inflammation and Metabolic Syndrome: A Review. Mol Nutr Food Res. 2026;70(3):e70360. PMID: 41622499 · DOI: 10.1002/mnfr.70360 [Mechanism Review]
- Sonia S, Witjaksono F, Ridwan R. Effect of cooling of cooked white rice on resistant starch content and glycemic response. Asia Pac J Clin Nutr. 2015;24(4):620-5. PMID: 26693746 [RCT, n=15]
- Strozyk S, Rogowicz-Frontczak A, Pilacinski S et al. Influence of resistant starch resulting from the cooling of rice on postprandial glycemia in type 1 diabetes. Nutr Diabetes. 2022;12(1):21. PMID: 35429987 · DOI: 10.1038/s41387-022-00196-1 [RCT, n=32]
- DeMartino P, Johnston EA, Petersen KS, Kris-Etherton PM, Cockburn DW. Additional Resistant Starch from One Potato Side Dish per Day Alters the Gut Microbiota but Not Fecal Short-Chain Fatty Acid Concentrations. Nutrients. 2022;14(3):721. PMID: 35277080 · DOI: 10.3390/nu14030721 [RCT, n=50]
- Canfora EE, Hermes GDA, Müller M et al. Fiber mixture-specific effect on distal colonic fermentation and metabolic health in lean but not in prediabetic men. Gut Microbes. 2022;14(1):2009297. PMID: 34923911 · DOI: 10.1080/19490976.2021.2009297 [RCT]
- Donohoe DR, Garge N, Zhang X et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517-26. PMID: 21531334 · DOI: 10.1016/j.cmet.2011.02.018 [In vivo, mouse]
- Zhao L, Zhang F, Ding X et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359(6380):1151-1156. PMID: 29590046 · DOI: 10.1126/science.aao5774 [RCT]
- Desai MS, Seekatz AM, Koropatkin NM et al. A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell. 2016;167(5):1339-1353.e21. PMID: 27863247 · DOI: 10.1016/j.cell.2016.10.043 [In vivo, mouse]
- Wilson B, Rossi M, Dimidi E, Whelan K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019;109(4):1098-1111. PMID: 30949662 · DOI: 10.1093/ajcn/nqy376 [Meta-analysis, k=11, n=729]
- Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(10):1044-1060. PMID: 30294792 · DOI: 10.1111/apt.15001 [Meta-analysis]
- Moayyedi P, Quigley EMM, Lacy BE et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1367-74. PMID: 25070054 · DOI: 10.1038/ajg.2014.195 [Meta-analysis, k=14, n=906]
- Zeraattalab-Motlagh S, Ranjbar M, Mohammadi H, Adibi P. Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials. Nutr Rev. 2025;83(3):e1343-e1354. PMID: 39110917 · DOI: 10.1093/nutrit/nuae107 [Systematic Review]
- Major G, Pritchard S, Murray K et al. Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology. 2017;152(1):124-133.e2. PMID: 27746233 · DOI: 10.1053/j.gastro.2016.09.062 [RCT, n=58]
- Yao CK, Tuck CJ. The clinical value of breath hydrogen testing. J Gastroenterol Hepatol. 2017;32 Suppl 1:20-22. PMID: 28244675 · DOI: 10.1111/jgh.13689 [Mechanism Review]
- Yao CK, Chu NHS, Tan VPY. Breath Hydrogen Testing in East and Southeast Asia. J Clin Gastroenterol. 2018;52(3):185-193. PMID: 29035975 · DOI: 10.1097/MCG.0000000000000943 [Mechanism Review]
- Depommier C, Everard A, Druart C et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. PMID: 31263284 · DOI: 10.1038/s41591-019-0495-2 [RCT, n=32]
- Everard A, Belzer C, Geurts L et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066-71. PMID: 23671105 · DOI: 10.1073/pnas.1219451110 [In vivo, mouse]
- Wastyk HC, Fragiadakis GK, Perelman D et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-4153.e14. PMID: 34256014 · DOI: 10.1016/j.cell.2021.06.019 [RCT, n=36]
- The two large meta-analyses come out sober. Neither Wilson 2019 nor Ford 2018 found a symptom benefit of prebiotics in irritable bowel syndrome, and Ford did not even arrive at a number for lack of data. This article does not carry that as a footnote, it builds a whole section on it.
- Conflicts of interest in four key studies. In Nagy 2023 (inulin), Yasukawa 2019 (guar gum), Calame 2008 (acacia fibre) and Canfora 2022 (inulin), authors were employed by manufacturers of the substrate under study. That does not devalue the data, but it belongs named.
- Acacia fibre rests on a single dose finding study with the surrogate endpoint of bacterial count. A clinical endpoint is missing. The good reputation comes from practice, not from the evidence base.
- Pectin is named here only as a substrate. No robust randomised trial with an endpoint on a gut symptom could be verified, so this text makes no statement about effect for it.
- Polyphenols are prebiotic like, not prebiotics. The crossover study covered 22 people, and the 2026 review collects no data of its own. That is not enough for the ISAPP definition.
- Akkermansia remains an open contradiction. In the mouse model only the live bacterium showed an effect, in the human pilot study with 32 people only the pasteurised one. This point is not smoothed over here.
- Resistant starch and butyrate. In DeMartino 2022 the microbiome shifted while faecal butyrate stayed unchanged. Faecal butyrate is, however, a poor marker, because most of it is already taken up by the gut epithelium. Both belong named together.
- Two circulating numbers are deliberately missing here. The twelve hour rule for resistant starch and the claim of 3.5 kilocalories less per 100 grams could not be traced to any primary study and are therefore not adopted.
- Sonia 2015 is deliberately listed with the PMID only. The publisher DOI does work in the browser but is not registered in the Crossref database. The case is similar for Collado Yurrita 2014: the DOI redirects correctly at the publisher and matches the PubMed record, but it is not deposited in Crossref. When in doubt, the PMID stands here.
- Animal data are marked as animal data. Donohoe 2011, Desai 2016 and Everard 2013 come from mouse models. They explain mechanisms and do not document an effect in humans.
- Regulatory context, not evidence. Statements from consumer bodies and authorities about permitted advertising claims are consumer information and not studies. They are not counted here as evidence.
- What is deliberately not here. No personal dosing recommendation, no build up plan with week numbers, no product name. The gram figures mentioned are study doses from the cited literature. Nothing in any section implies skipping a recommended assessment or changing ongoing medication on your own. What I describe from my consultation room is marked as observation and is not a study result.